These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 10827454)

  • 1. RTK mutations and human syndromeswhen good receptors turn bad.
    Robertson SC; Tynan JA; Donoghue DJ
    Trends Genet; 2000 Jun; 16(6):265-71. PubMed ID: 10827454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [From gene to disease; craniosynostosis syndromes due to FGFR2-mutation].
    van Ravenswaaij-Arts CM; van den Ouweland AM; Hoogeboom AJ; Herbergs J; Pals G
    Ned Tijdschr Geneeskd; 2002 Jan; 146(2):63-6. PubMed ID: 11820058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular basis of human piebaldism.
    Spritz RA
    J Invest Dermatol; 1994 Nov; 103(5 Suppl):137S-140S. PubMed ID: 7525736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rare SNPs in receptor tyrosine kinases are negative outcome predictors in multiple myeloma.
    Keppler S; Weiβbach S; Langer C; Knop S; Pischimarov J; Kull M; Stühmer T; Steinbrunn T; Bargou R; Einsele H; Rosenwald A; Leich E
    Oncotarget; 2016 Jun; 7(25):38762-38774. PubMed ID: 27246973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutation detection in FGFR2 craniosynostosis syndromes.
    Hollway GE; Suthers GK; Haan EA; Thompson E; David DJ; Gecz J; Mulley JC
    Hum Genet; 1997 Feb; 99(2):251-5. PubMed ID: 9048930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Constitutive receptor activation by Crouzon syndrome mutations in fibroblast growth factor receptor (FGFR)2 and FGFR2/Neu chimeras.
    Galvin BD; Hart KC; Meyer AN; Webster MK; Donoghue DJ
    Proc Natl Acad Sci U S A; 1996 Jul; 93(15):7894-9. PubMed ID: 8755573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Receptor tyrosine kinase mutations in developmental syndromes and cancer: two sides of the same coin.
    McDonell LM; Kernohan KD; Boycott KM; Sawyer SL
    Hum Mol Genet; 2015 Oct; 24(R1):R60-6. PubMed ID: 26152202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The RET proto-oncogene in human cancers.
    Jhiang SM
    Oncogene; 2000 Nov; 19(49):5590-7. PubMed ID: 11114739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic predisposition to phaeochromocytoma: analysis of candidate genes GDNF, RET and VHL.
    Woodward ER; Eng C; McMahon R; Voutilainen R; Affara NA; Ponder BA; Maher ER
    Hum Mol Genet; 1997 Jul; 6(7):1051-6. PubMed ID: 9215674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human piebaldism: relationship between phenotype and site of kit gene mutation.
    Ward KA; Moss C; Sanders DS
    Br J Dermatol; 1995 Jun; 132(6):929-35. PubMed ID: 7544995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spectrum of craniosynostosis phenotypes associated with novel mutations at the fibroblast growth factor receptor 2 locus.
    Pulleyn LJ; Reardon W; Wilkes D; Rutland P; Jones BM; Hayward R; Hall CM; Brueton L; Chun N; Lammer E; Malcolm S; Winter RM
    Eur J Hum Genet; 1996; 4(5):283-91. PubMed ID: 8946174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identical mutations in three different fibroblast growth factor receptor genes in autosomal dominant craniosynostosis syndromes.
    Bellus GA; Gaudenz K; Zackai EH; Clarke LA; Szabo J; Francomano CA; Muenke M
    Nat Genet; 1996 Oct; 14(2):174-6. PubMed ID: 8841188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Multiple endocrine neoplasia: a clinical model for applying molecular genetic techniques].
    Wohllk N; Becker P; Véliz J; Pineda G
    Rev Med Chil; 2000 Jul; 128(7):791-800. PubMed ID: 11050843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of receptor tyrosine kinase transmembrane domains in cell signaling and human pathologies.
    Li E; Hristova K
    Biochemistry; 2006 May; 45(20):6241-51. PubMed ID: 16700535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutation-introduced dimerization of receptor tyrosine kinases: from protein structure aberrations to carcinogenesis.
    Hu H; Liu Y; Jiang T
    Tumour Biol; 2015 Mar; 36(3):1423-8. PubMed ID: 25750036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single missense mutation in the tyrosine kinase catalytic domain of the RET protooncogene is associated with multiple endocrine neoplasia type 2B.
    Carlson KM; Dou S; Chi D; Scavarda N; Toshima K; Jackson CE; Wells SA; Goodfellow PJ; Donis-Keller H
    Proc Natl Acad Sci U S A; 1994 Feb; 91(4):1579-83. PubMed ID: 7906417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations of the ret protooncogene in German multiple endocrine neoplasia families: relation between genotype and phenotype. German Medullary Thyroid Carcinoma Study Group.
    Frank-Raue K; Höppner W; Frilling A; Kotzerke J; Dralle H; Haase R; Mann K; Seif F; Kirchner R; Rendl J; Deckart HF; Ritter MM; Hampel R; Klempa J; Scholz GH; Raue F
    J Clin Endocrinol Metab; 1996 May; 81(5):1780-3. PubMed ID: 8626834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel FGFR2 mutations in Crouzon and Jackson-Weiss syndromes show allelic heterogeneity and phenotypic variability.
    Park WJ; Meyers GA; Li X; Theda C; Day D; Orlow SJ; Jones MC; Jabs EW
    Hum Mol Genet; 1995 Jul; 4(7):1229-33. PubMed ID: 8528214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combinatorial inhibition of PTPN12-regulated receptors leads to a broadly effective therapeutic strategy in triple-negative breast cancer.
    Nair A; Chung HC; Sun T; Tyagi S; Dobrolecki LE; Dominguez-Vidana R; Kurley SJ; Orellana M; Renwick A; Henke DM; Katsonis P; Schmitt E; Chan DW; Li H; Mao S; Petrovic I; Creighton CJ; Gutierrez C; Dubrulle J; Stossi F; Tyner JW; Lichtarge O; Lin CY; Zhang B; Scott KL; Hilsenbeck SG; Sun J; Yu X; Osborne CK; Schiff R; Christensen JG; Shields DJ; Rimawi MF; Ellis MJ; Shaw CA; Lewis MT; Westbrook TF
    Nat Med; 2018 May; 24(4):505-511. PubMed ID: 29578538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple endocrine neoplasia type 2 and RET: from neoplasia to neurogenesis.
    Hansford JR; Mulligan LM
    J Med Genet; 2000 Nov; 37(11):817-27. PubMed ID: 11073534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.